Literature DB >> 6482311

Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.

R Herz, M Rössle, T Bonzel, E Keller, W Gerok.   

Abstract

The effect of cimetidine on hepatic and systemic haemodynamic parameters was studied in seven patients with portal hypertension due to alcohol-induced cirrhosis of the liver and in one patient with peliosis hepatis following oral contraceptive steroids. The intravenous administration of cimetidine (350 mg as bolus, followed by 2 mg/min over 60 min) reduced the hepatic extraction of continuously infused indocyanine green (ICG) by 27%; this was statistically significant (P less than 0.01). Since the ICG clearance, calculated independently of hepatic perfusion, was lowered by 19%, this effect seems to be mainly due to a reduced capacity of the liver to remove the dye from the blood, rather than due to changes in perfusion. Cimetidine did not influence the elevated portal pressure in the patients with cirrhosis, or the normal pressure in the patient with peliosis hepatis. No significant effect was observed on heart rate, mean arterial pressure, pulmonary artery pressure, pulmonary capillary pressure and cardiac output. These studies indicate that the reduction of the hepatic ICG extraction following cimetidine is more the result of an inhibited capacity of the liver to remove the dye than of changes in the hepatic perfusion or in the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6482311     DOI: 10.1007/bf01721773

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  25 in total

1.  A comparison of the effects of bradykinin, 5-hydroxytryptamine and histamine on the hepatic arterial and portal venous vascular beds of the dog: histamine H1 and H2-receptor populations.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  [What does the BSP retention measure? Comparison of BSP-transport maximum, storage capacity and capacity for elimination of galactose].

Authors:  B Imesch; W Häcki; J Bircher
Journal:  Schweiz Med Wochenschr       Date:  1973-03-17

3.  Effect of cimetidine on portal hypertension in cirrhotic patients.

Authors:  A K Burroughs; R Walt; A Dunk; W Jenkins; S Sherlock; S Mackie; R Dick
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-17

4.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

5.  The effects of chronic oral cimetidine therapy on the cardiovascular system in man.

Authors:  S Saltissi; A Crowther; C Byrne; D J Coltart
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

6.  A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.

Authors:  W Häcki; J Bircher; R Preisig
Journal:  J Lab Clin Med       Date:  1976-12

7.  Effect of histamine and histamine antagonists on portal blood pressure in patients with hepatosplenic schistosomiasis.

Authors:  M A El-Gendi; S H Nassar
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

8.  [Hepatic extraction of taurocholate and indocyanine green in patients with liver disease (author's transl)].

Authors:  G Paumgartner; D L Vasella; R Herz; J Reichen; R Preisig
Journal:  Z Gastroenterol       Date:  1979-11       Impact factor: 2.000

9.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

10.  Gastric mucosal blood flow and acid secretory changes in man with impromidine: a new specific histamine-H2-receptor agonist.

Authors:  R L McIsaac; B J Johnston; L P Fielding
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

View more
  6 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy.

Authors:  R Herz; H J Halbfass; M Rössle; D Waldmann; W Gerok
Journal:  Klin Wochenschr       Date:  1985-05-02

Review 3.  The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-11-02

4.  Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

Authors:  P A Soons; A De Boer; A F Cohen; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 5.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

6.  Cardiovascular effects of tolazoline and ranitidine.

Authors:  A Bush; C M Busst; W B Knight; E A Shinebourne
Journal:  Arch Dis Child       Date:  1987-03       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.